Related Experiment Videos
Uterine papillary serous carcinoma evolves via a p53-driven pathway
U M Moll1, E Chalas, M Auguste
1Department of Pathology, University Hospital, State University of New York at Stony Brook, NY 11794-8691, USA.
Human Pathology
|December 1, 1996
Summary
Uterine papillary serous carcinoma (UPSC) is strongly linked to p53 overexpression, not hormone dependence. Early p53 alterations drive this aggressive cancer, leading to poorer survival rates.
Area of Science:
- Oncology
- Molecular Pathology
- Gynecologic Oncology
Background:
- Uterine papillary serous carcinoma (UPSC) is an aggressive endometrial cancer subtype.
- UPSC is characterized by hypoestrogenism, advanced stage, and poor prognosis.
- Loss of p53 function is implicated in the pathogenesis of this tumor group.
Purpose of the Study:
- To investigate the role of p53 alterations in UPSC.
- To assess the association between p53 expression and clinicopathologic features.
- To evaluate the correlation of p53 status with patient survival.
Main Methods:
- Immunohistochemical analysis of p53 expression in 40 UPSC tumors.
- Assessment of estrogen and progesterone receptor expression.
- Correlation of p53 overexpression with survival data.
Main Results:
- 85% of UPSC tumors showed intense nuclear p53 overexpression.
- p53 alterations were consistent across multiple tumor sites, indicating early occurrence.
- p53 overexpression was associated with loss of hormone receptors and significantly shorter survival (P=.03).
Conclusions:
- UPSC is a p53-driven neoplasm, distinct from hormone-dependent endometrial cancers.
- Early p53 alterations are critical in UPSC development and aggressive behavior.
- Findings support broadening the concept of UPSC to include other p53-driven serous papillary malignancies.